mafosfamide has been researched along with cyclosporine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pukhal'skiĭ, AL; Toptygina, AP | 1 |
| Carreras, E; Diaz-Ricart, M; Escolar, G; Martinez-Sanchez, J; Moreno-Castaño, AB; Palomo, M; Pascual-Diaz, R; Rovira, M; Salas, MQ; Ventosa, H | 1 |
2 other study(ies) available for mafosfamide and cyclosporine
| Article | Year |
|---|---|
[Comparative study of mechanisms of antiproliferative action of low concentrations of mafosfamide and cyclosporin A].
Topics: Animals; Cell Division; Cells, Cultured; Cyclophosphamide; Cyclosporine; Male; Mice; Mice, Inbred Strains; Species Specificity; Spleen | 1993 |
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro.
Topics: Cyclophosphamide; Cyclosporine; Endothelial Cells; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Proto-Oncogene Proteins c-akt; Vascular Cell Adhesion Molecule-1; von Willebrand Factor | 2023 |